LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 8.12
(0.25%)
CNY 8.12
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16 Billion | 1.01 Billion | 817.64 Million | 668.05 Million | 628.81 Million | 544.58 Million |
| Cost of Revenue | 801.83 Million | 732.96 Million | 594.49 Million | 502.66 Million | 461.62 Million | 369.73 Million |
| Gross Profit | 361.29 Million | 286.21 Million | 223.14 Million | 165.38 Million | 167.19 Million | 174.84 Million |
| Operating Expenses | 275.68 Million | 129.37 Million | 134.55 Million | 109.35 Million | 98.33 Million | 112.82 Million |
| Selling, General and Administrative Expenses | 174.81 Million | 115.56 Million | 90.83 Million | 80.54 Million | 103.77 Million | 70.27 Million |
| Research and Development Expenses | 30.92 Million | 23.55 Million | 19.35 Million | 15.38 Million | 20.64 Million | 19.51 Million |
| Other Expenses | -7.05 Million | -9.74 Million | 24.36 Million | 13.43 Million | -26.08 Million | 335.5 Thousand |
| Cost and Expenses | 1.07 Billion | 862.33 Million | 729.04 Million | 612.01 Million | 559.95 Million | 482.55 Million |
| Operating Income | 83.27 Million | 139.4 Million | 112.36 Million | 64.43 Million | 78.24 Million | 86.14 Million |
| Interest Expense | 1.47 Million | 678.05 Thousand | 945.58 Thousand | 1.27 Million | 1.12 Million | 642 Thousand |
| Income Tax Expense | 13.51 Million | 21.06 Million | 17.29 Million | 22.81 Million | 7.81 Million | 13.56 Million |
| Earnings before Tax | 81.64 Million | 126.99 Million | 110.81 Million | 130.52 Million | 78.73 Million | 86.47 Million |
| Net Income | 67.18 Million | 108.65 Million | 93.25 Million | 108.01 Million | 71.1 Million | 72.91 Million |
| Earnings Per Share Basic | 0.13 | 0.21 | 0.18 | 0.21 | 0.15 | 0.14 |
| Earnings Per Share Diluted | 0.13 | 0.21 | 0.18 | 0.21 | 0.15 | 0.14 |
| Weighted Average Shares Outstanding | 510.65 Million | 510.65 Million | 510.65 Million | 510.65 Million | 510.65 Million | 510.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.65 Million | 510.65 Million | 510.65 Million | 510.65 Million | 510.65 Million | 510.63 Million |
| Gross Margin | 0.31 | 0.28 | 0.27 | 0.25 | 0.27 | 0.32 |
| EBIT Margin | 0.12 | 0.20 | 0.18 | 0.15 | 0.22 | 0.23 |
| Profit Margin | 0.06 | 0.11 | 0.11 | 0.16 | 0.11 | 0.13 |
| EBITDA | 135.36 Million | 190.35 Million | 161.95 Million | 58.41 Million | 141.09 Million | 123.24 Million |
| Earnings Before Tax Margin | 0.07 | 0.14 | 0.14 | 0.10 | 0.12 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 209.65 Million | 221.55 Million | 274.32 Million | 1.16 Billion | 302.62 Million | 251.47 Million |
| Cost of Revenue | 146.76 Million | 150.55 Million | 189.02 Million | 801.83 Million | 189.98 Million | 194.1 Million |
| Gross Profit | 62.88 Million | 71 Million | 85.3 Million | 361.29 Million | 112.63 Million | 57.37 Million |
| Operating Expenses | 49.65 Million | 58.4 Million | 52.14 Million | 261.96 Million | 79.46 Million | 54.07 Million |
| Selling, General and Administrative Expenses | 75.67 Million | 51.54 Million | 46.75 Million | - | 6.98 Million | 75.67 Million |
| Research and Development Expenses | 7.14 Million | 6.84 Million | 6.88 Million | - | 9.66 Million | 6.35 Million |
| Other Expenses | -33.16 Million | -17.68 Thousand | -396.61 Thousand | -1.63 Million | -680.18 Thousand | 495.93 |
| Cost and Expenses | 196.41 Million | 208.96 Million | 241.17 Million | 1.06 Billion | 269.44 Million | 248.17 Million |
| Operating Income | 4.06 Million | 12.59 Million | 22.99 Million | 83.27 Million | 8.02 Million | 5.26 Million |
| Interest Expense | 558.13 Thousand | - | - | 1.24 Million | - | - |
| Income Tax Expense | 495.35 Thousand | 766.66 Thousand | 3.96 Million | 13.51 Million | -1.73 Million | 3.06 Million |
| Earnings before Tax | 3.88 Million | 20.02 Million | 22.6 Million | 81.64 Million | 7.34 Million | 5.26 Million |
| Net Income | 2.97 Million | 17.7 Million | 18.38 Million | 67.18 Million | 8.07 Million | 2.06 Million |
| Earnings Per Share Basic | 0.01 | 0.03 | 0.04 | - | 0.02 | 0.00 |
| Earnings Per Share Diluted | 0.01 | 0.03 | 0.04 | - | 0.02 | 0.00 |
| Weighted Average Shares Outstanding | 510.65 Million | 510.65 Million | 510.75 Million | 510.56 Million | 510.65 Million | 510.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.65 Million | 510.65 Million | 510.75 Million | 510.56 Million | 510.65 Million | 510.65 Million |
| Gross Margin | 0.30 | 0.32 | 0.31 | 0.31 | 0.37 | 0.23 |
| EBIT Margin | 0.02 | 0.13 | 0.15 | - | 0.12 | -0.02 |
| Profit Margin | 0.01 | 0.08 | 0.07 | 0.06 | 0.03 | 0.01 |
| EBITDA | 4.43 Million | 28.16 Million | 41.15 Million | - | 36.87 Million | -4.15 Million |
| Earnings Before Tax Margin | 0.02 | 0.06 | 0.08 | 0.07 | 0.03 | 0.02 |
TUD
ASURB
000900
PROX
SEAL-PA
HTFC